Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug safety
Pharma
Pfizer confirms patient death in hemophilia drug trial
A patient in a study of Pfizer’s hemophilia drug Hympavzi has passed away, the company and several hemophilia advocacy groups confirmed this week.
Fraiser Kansteiner
Dec 23, 2025 11:05am
FDA safety probe, Otsuka, ADC patent fight—Fierce Pharma Asia
Dec 5, 2025 8:45am
FDA probes safety of Takeda's Adzynma after reported death
Nov 21, 2025 11:40am
Fresenius, Sun, Teva and others launched drug recalls this fall
Nov 12, 2025 3:55pm
Texas AG sues Kenvue over alleged Tylenol-autism link
Oct 28, 2025 1:16pm
Trump officials to link COVID shots, child deaths: WaPo
Sep 12, 2025 2:47pm
